Search research articles
Contact Us
Filters
Showing results (1-10 of 82) with videos related to
Page
of 9
Sort By:
The New Zealand Medical Journal
|
July 27, 2006
Optimising Chlamydia testing within constrained funding
Arthur J Morris, Michael McCarthy
The Lancet. Infectious Diseases
|
May 30, 2020
Surgical antibiotic prophylaxis: more is not better
Sally A Roberts, Arthur J Morris
Journal of Clinical Microbiology
|
October 9, 2004
Clinical benefit of recovering dermatophytes from skin swabs sent for bacterial culture
Gillian Mabbott, Jocelyn Smith, Arthur J Morris
Pathology
|
April 27, 2011
The frequency and potential clinical impact of non-analytical errors in the RCPA Microbiology QAP 1987-2008
Arthur J Morris, Elizabeth Haremza, Debra A Walker
Infection Control and Hospital Epidemiology
|
April 10, 2003
Modeling the costs of hospital-acquired infections in New Zealand
Nicholas Graves, Tanya M Nicholls, Arthur J Morris
BMJ (Clinical Research Ed.)
|
September 10, 2020
Should countries aim for elimination in the covid-19 pandemic?
Andrew Lee, Simon Thornley, Arthur J Morris, et al.
The New Zealand Medical Journal
|
May 7, 2026
Antifungal susceptibility of genital yeast isolates, Auckland, 2016-2025
Arthur J Morris, Wendy P McKinney, Sally A Roberts
The New Zealand Medical Journal
|
February 7, 2020
Healthcare-associated Staphylococcus aureus bacteraemia: time to reduce the harm caused by a largely preventable event
Sally Roberts, Nikki Grae, Sharmini Muttaiyah, et al.
The New Zealand Medical Journal
|
October 29, 2003
Antibiotic susceptibility of Haemophilus influenzae isolates from four New Zealand sites
Arthur J Morris, Rosemary Ikram, Mark Jones, et al.
The New Zealand Medical Journal
|
October 12, 2004
Antifungal susceptibility of non-albicans Candida species causing fingernail onychomycosis
Arlo Upton, Karen Rogers, Neil Wood, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 82) with videos related to
Sort By:
Page
of 9
The New Zealand Medical Journal
|
July 27, 2006
Optimising Chlamydia testing within constrained funding
Arthur J Morris, Michael McCarthy
The Lancet. Infectious Diseases
|
May 30, 2020
Surgical antibiotic prophylaxis: more is not better
Sally A Roberts, Arthur J Morris
Journal of Clinical Microbiology
|
October 9, 2004
Clinical benefit of recovering dermatophytes from skin swabs sent for bacterial culture
Gillian Mabbott, Jocelyn Smith, Arthur J Morris
Pathology
|
April 27, 2011
The frequency and potential clinical impact of non-analytical errors in the RCPA Microbiology QAP 1987-2008
Arthur J Morris, Elizabeth Haremza, Debra A Walker
Infection Control and Hospital Epidemiology
|
April 10, 2003
Modeling the costs of hospital-acquired infections in New Zealand
Nicholas Graves, Tanya M Nicholls, Arthur J Morris
BMJ (Clinical Research Ed.)
|
September 10, 2020
Should countries aim for elimination in the covid-19 pandemic?
Andrew Lee, Simon Thornley, Arthur J Morris, et al.
The New Zealand Medical Journal
|
May 7, 2026
Antifungal susceptibility of genital yeast isolates, Auckland, 2016-2025
Arthur J Morris, Wendy P McKinney, Sally A Roberts
The New Zealand Medical Journal
|
February 7, 2020
Healthcare-associated Staphylococcus aureus bacteraemia: time to reduce the harm caused by a largely preventable event
Sally Roberts, Nikki Grae, Sharmini Muttaiyah, et al.
The New Zealand Medical Journal
|
October 29, 2003
Antibiotic susceptibility of Haemophilus influenzae isolates from four New Zealand sites
Arthur J Morris, Rosemary Ikram, Mark Jones, et al.
The New Zealand Medical Journal
|
October 12, 2004
Antifungal susceptibility of non-albicans Candida species causing fingernail onychomycosis
Arlo Upton, Karen Rogers, Neil Wood, et al.
Page
of 9